Gastrointestinal dysfunctions represent one of the main non-motor symptoms in Parksinon’s disease (PD). Prof. Angelo Antonini (Professor of Neurology, University of Padua, Padua, Italy) discusses a study that investigated α-Synuclein seeding activity in stomach-duodenum biopsies of PD patients by real-time quaking induced conversion (RT-QuIC) assay. The results suggest a deeper investigation in detection of α-Synuclein seeding activity in the early stages of PD in gastrointestinal biopsies via RT-QuIC as an early biomarker of disease.
The abstract entitled: ‘Detection of α-Synuclein Seeding Activity by RT-QUIC Assay in Gastrointestinal Biopsies of Patients with Advanced Parkinson’s Disease’ was presented at the International Conference of Alzheimer’s and Parkinson’s diseases and related neurological disorders (AD/PD), 13-15 October 2021.
- What unmet needs exist in the detection of the prodromal phase of Parkinson’s disease (PD)? (0:20)
- What evidence is there to support the hypothesis that α-Synuclein seeding activity occurs in the gastrointestinal tract in PD? (3:32)
- What were the aims and methodology, study findings? (5:49)
- What will be the next stages of this research? (8:13)
Disclosures: Prof. Angelo Antonini is a consultant for AbbVie, Bial, Biopharma, Britannia, Ever Pharma, UCB, Jazz Pharmaceuticals, Kyowa Kirin, Theravance, Roche, Zambon; receives grant/research support from Bial, Lundbeck, Roche, Angelini Pharmaceuticals, Horizon 2020 – Grant 825785, Horizon2020 Grant 101016902, Ministry of Education University and Research (MIUR) Grant ARS01_01081, Cariparo Foundation, and Movement Disorders Society.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch
Filmed as a highlight of AD/PD 2022.
Share this Video
Related Videos In Parkinson's Disease
Angelo Antonini, EAN 2023: Highlights in Parkinson’s disease
touchNEUROLOGY editorial board member Prof. Angelo Antonini (Padua University Hospital, Italy) provides an overview of his top three most important updates and hot topics from the annual European Academy of Neurology (EAN), July 1–4, 2023, in the field of Parkinson’s disease. He particularly focusses on new insights in early detection of the disease before motor symptoms […]
Highlights from EAN 2023!
Veronica Clark, Parkinson’s Europe: Presidential Update, and the Parkinson’s Manifesto for Europe
The European Parkinson’s Disease Association (EPDA) recently changed its name to Parkinson’s Europe. They are the only European Parkinson’s umbrella organisation and have been working with the global Parkinson’s community for nearly 30 years. As a leading voice for Parkinson’s in Europe, they provide trusted information; advance and share good practices; raise awareness and improve […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!